Smoking weed may increase the risk of developing lung cancer
I would carry it in an old Kodiak can and get a dip whenever I had the urge
In 428.101(a), CMS proposes to identify a Part D rebatable drug [580] for each applicable period by determining which covered Part D drugs, as defined in section 1860D-2(e) of the Act, meet the requirements in section 1860D-14B(g)(1)(C) of the Act (that is, are brand name drugs approved under an NDA, biologicals licensed under a biologics license application (BLA), or generic drugs approved under an ANDA)
Lets explore what this ruling means and how it will impact smoking rates
Customer service is great. Jim A
[PubMed: 2716759] Bartalesi B, Cavarra E, Fineschi S, Lucattelli M, Lunghi B, Martorana PA, Lungarella G